$AFCG

TANNENBAUM LEONARD M purchased $88K of AFCG

TANNENBAUM LEONARD M purchased 25,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.50 on 2026-09-17.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Sep 18, 2026, 8:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AFCG
Neutral
medium confidence
Mentioned
$AFCG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The insider buy adds a small amount to existing holdings, offering limited insight for traders.

02

Market read

Routine insider purchase with modest size; low trading relevance.

03

What to watch

Potential upcoming financing or corporate actions not disclosed in the filing.

Relevance 4/10Novelty 3/10Timing: post‑market 2026‑09‑18

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$AFCGNeutralMedium confidence
Context

Director Leonard Tannenbaum purchased 25,000 shares of Advanced Flower Capital at $3.50 each, total $87,500.

Expected impact

Limited short‑term price lift; unlikely to move the stock materially.

Evidence & confidence

The transaction is a routine 8‑K Form 4 filing; size is small and does not indicate a major strategic shift.

Market effects

No immediate sector impact; the filing is specific to Advanced Flower Capital.

None

None

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a bullish signal.

Key entities

  • Advanced Flower Capital Inc.

    Issuer of the Form 4 filing.

  • Leonard Tannenbaum

    Director and 10% owner of Advanced Flower Capital.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): AFC Announces Financial Results for the Second Quarter 2026

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.